MapLight Therapeutics, Inc. (MPLT) vs Ocugen, Inc. (OCGN)
A side-by-side comparison of MapLight Therapeutics, Inc. and Ocugen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MPLT
MapLight Therapeutics, Inc.
$9.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
OCGN
Ocugen, Inc.
$1.04HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MPLT vs OCGN
growth of $100 · dividends reinvested · last 1yMPLT -49.4% (-49.4%/yr)OCGN -35.4% (-35.4%/yr)OCGN compounded faster over this window
MPLT OCGN
MPLT vs OCGN: by the numbers
- •MPLT is the larger company ($411M vs $353M market cap).
- •Both run net losses; MPLT's is the smaller (0.00% vs -1786.27% net margin).
Metrics side by side
Valuation
| Metric | MPLT | OCGN |
|---|---|---|
| P/S ratio | N/A | 77.00 |
| P/B ratio | 1.18 | N/A |
Profitability
| Metric | MPLT | OCGN |
|---|---|---|
| Gross margin | 0.00% | 45.86% |
| Operating margin | 0.00% | -1425.70% |
| Net margin | 0.00% | -1786.27% |
| ROE | -65.99% | N/A |
| ROIC | -69.35% | -93.74% |
Growth (annualized)
| Metric | MPLT | OCGN |
|---|---|---|
| Total return CAGR (5Y) | N/A | -31.57% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.